A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program
2022
JAMA Network Open
Preserved Fulltext
This cross-sectional study estimates the trial capacity of sites participating in the COVID-19 convalescent plasma expanded access program.
doi:10.1001/jamanetworkopen.2022.37540
pmid:36260335
fatcat:fc4pkqbyxne57jhonc4dq755xi